The incidence and mortality rate of esophageal cancer in China fell by around 4.5 percent annually, according to the figures ...

Pancreatic cancer is one of the most difficult cancers to treat, with an overall five-year survival rate of 13%, according to ...

Why childhood obesity is becoming a cause for concern in a country that now ranks second globally for kids who are overweight ...

Kailera Therapeutics soared 63% in its NASDAQ debut, marking the largest biotech IPO since 2021. Backed by Bain Capital, the ...

Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs who joined the “$30 million club.” ...

Kennedy fielded questions from both sides of the aisle during a marathon session of back-to-back hearings before the House.

A steep slide in housing prices has left consumers less prosperous and less willing to spend, but the government is pouring ...

Strong exports of electrical and mechanical products supercharged China’s economy in the first three months of the year, with ...

Beijing had lowered its growth target this year to a range of 4.5% to 5%, the least ambitious goal on record going back to ...

Primary liver cancer continues to pose a major global health challenge, ranking as the third leading cause of cancer-related deaths worldwide.

Can Eli Lilly (NYSE: LLY) stock surge 2x to $2,000 in the coming years? We believe that this is indeed a genuine possibility.